Saranac Partners »

Esperion Therapeutics Inc Ne shares owned by Saranac Partners

Quarter-by-quarter ownership of Esperion Therapeutics Inc Ne shares owned by Saranac Partners from 13F filings

Historical chart of Saranac Partners investment in Esperion Therapeutics Inc Ne

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics Inc Ne held by Saranac Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics Inc Ne by Saranac Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $501k 500k 1.00

More positions owned by Saranac Partners

iShares III PLC - iShares Core MSCI World UCITS ETF Etf (IRRRF)
iShares IV PLC - iShares US Mortgage Backed Securities UCITS ETF Etf (IMBXF)
iShares PLC - iShares Core MSCI EM IMI UCITS ETF Etf (ISAPF)
iShares PLC - iShares USD Corp Bond UCITS ETF Etf (ISCXF)
Microsoft Corp #n/a (MSFT)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co #n/a (JPM)
Mastercard #n/a (MA)
Shell Common stock (RYDAF)
Apple (AAPL)
Enel Spa (ESOCF)
TJX Companies #n/a (TJX)
iShares VI PLC - iShares Edge MSCI World Minimum Volatility UCITS ETF Etf (IEMXF)
Abbvie (ABBV)

View all positions for Saranac Partners

Top funds holding Esperion Therapeutics Inc Ne

Pentwater Capital Management
DeepCurrents Investment Group
PenderFund Capital Management
Oaktree Capital Management
Leucadia National Corporation
Russell Investments
Saranac Partners
Zazove Associates
Context Capital Management

View all funds holding Esperion Therapeutics Inc Ne